8 steps to nodule enlightenment
Sponsored by AstraZeneca and 4D Medical
| 1000-1300 | Postgraduate Workshop: 8 steps to nodule enlightenment | |
| Chair: Gerard Olive | ||
| 1000-1005 | Intro | Gerard Olive |
| 1005-1015 | Do I look like cancer: Who, when, how? Nodule presentation in clinical practice | Archit Chawla |
| 1015-1025 | Do I look like cancer: Practical tips and tricks for CT image reading | Catherine Jones |
| 1025-1035 | Predicting cancer risk: PLCO, PanCan, LLP, and other models | Fraser Brims |
| 1035-1045 | Metrics and volumes: Utility, ease, technical specifics / practical tips and tricks for nodule features and reporting | Catherine Jones |
| 1045-1055 | Growing up - natural hx: Specifics on GGOs and subsolids! Especially in Asian populations | Tracy Leong |
| 1055-1105 | Biopsy – who, when, how, why not: How to? | Dave Manners |
| 1105-1115 | Biopsy – who, when, how, why not: CT-guided biopsy | Morgan Schulze |
| 1115-1125 | MDT virtual care: Pros, cons, of MDT nodule care. How to streamline MDT decision making for nodules possibly cancer | Gerard Olive |
| 1130-1200 | Morning Tea | |
| 1200-1210 | Marking time (watch and wait): When don't I need a biopsy to operate? | Philippa Bowers |
| 1210-1220 | Marking time (watch and wait): When don't I need a biopsy to SABR? | Catherine Bettington |
| 1220-1225 | All the same – LCS vs incidental: Are they different clinically and prognostically? | Archit Chawla |
| 1225-1230 | All the same – LCS vs incidental: Review differences in GLs for LCS Vs incidental nodules | Catherine Jones |
| 1230-1250 | Questions and cases | Moderator: Gerard Olive |
| 1250-1300 | Close |
Key Dates
ABSTRACT SUBMISSION
CLOSED
EARLYBIRD REGISTRATION
OPEN
EARLYBIRD DEADLINE
19 January 2026